(Reuters) – The German pharmaceutical and pesticide group Bayer AG said on Thursday that it will pay about $ 1.6 billion to settle the majority of US claims with its Essure birth control device.
The agreement follows a $ 10.9 billion settlement in June of US lawsuits alleging the company's herbicide Roundup caused cancer.
Bayer said that the Essure settlement is for about 90% of the nearly 39,000 claims of women who were allegedly harmed by the entities and that it was discussed with lawyers for the remaining complainants.  "There is no acknowledgment of Bayer's misconduct or liability in the settlement agreements," Bayer said.
Women have argued in lawsuits that the device, which is implanted in the fallopian tubes to permanently block the transfer of eggs to the uterus, could penetrate the tubes, and that the metal parts of the device could loosen and migrate to other parts of the body.
Bayer said in 201